Human tumor antigens yesterday, today, and tomorrow

OJ Finn - Cancer immunology research, 2017 - AACR
The question of whether human tumors express antigens that can be recognized by the
immune system has been answered with a resounding YES. Most were identified through …

Antibodies as biomarkers for cancer risk: a systematic review

MJ Monroy-Iglesias, S Crescioli… - Clinical and …, 2022 - academic.oup.com
Increasing evidence has linked the humoral immune response with the development of
various cancers. Therefore, there is growing interest in investigating the predictive value of …

Identification of 5 Hub Genes Related to the Early Diagnosis, Tumour Stage, and Poor Outcomes of Hepatitis B Virus‐Related Hepatocellular Carcinoma by …

R Qiang, Z Zhao, L Tang, Q Wang… - … Methods in Medicine, 2021 - Wiley Online Library
Background. The majority of primary liver cancers in adults worldwide are hepatocellular
carcinomas (HCCs, or hepatomas). Thus, a deep understanding of the underlying …

[HTML][HTML] Regulating the CCNB1 gene can affect cell proliferation and apoptosis in pituitary adenomas and activate epithelial‑to‑mesenchymal transition

B Li, HB Zhu, GD Song, JH Cheng, CZ Li… - Oncology …, 2019 - spandidos-publications.com
The aim of the present study was to investigate the role and potential regulatory
mechanisms of cyclin B1 (CCNB1) in the proliferation, apoptosis and epithelial‑to …

[HTML][HTML] Prognostic role of cyclin B1 in solid tumors: a meta-analysis

C Ye, J Wang, P Wu, X Li, Y Chai - Oncotarget, 2017 - ncbi.nlm.nih.gov
Cyclin B1 is a key mitotic cyclin in the G2-M phase transition of the cell cycle and is
overexpressed in various malignant tumors. Numerous studies have reported contradictory …

Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis

Y Wang, Z Zhou, L Chen, Y Li, Z Zhou… - Molecular and Cellular …, 2021 - Springer
Lung adenocarcinoma (LUAD) accounts for the majority of cancer-related deaths worldwide.
Our study identified key LUAD genes and their potential mechanism via bioinformatics …

In silico analysis revealed the potential circRNA-miRNA-mRNA regulative network of non-small cell lung cancer (NSCLC)

A Balasundaram - Computers in Biology and Medicine, 2023 - Elsevier
Background The primary source of death in the world is non-small cell lung cancer
(NSCLC). However, NSCLCs pathophysiology is still not completely understood. The current …

The tumor antigen cyclin B1 hosts multiple CD4 T cell epitopes differently recognized by pre-existing naive and memory cells in both healthy and cancer donors

C Chevaleyre, N Benhamouda, E Favry… - The Journal of …, 2015 - journals.aai.org
Abstract Cyclin B1 (CCNB1) is considered as a potential target for a cancer vaccine, as it is
overexpressed in many malignant cells, while being transiently expressed in normal cells …

Cathepsin L knockdown enhances curcumin-mediated inhibition of growth, migration, and invasion of glioma cells

Y Fei, Y Xiong, Y Zhao, W Wang, M Han, L Wang… - Brain Research, 2016 - Elsevier
Curcumin can be used to prevent and treat cancer. However, its exact underlying molecular
mechanisms remain poorly understood. Cathepsin L, a lysosomal cysteine protease, is …

[HTML][HTML] A squalamine derivative, NV669, as a novel PTP1B inhibitor: In vitro and in vivo effects on pancreatic and hepatic tumor growth

S Carmona, JM Brunel, R Bonier, V Sbarra, S Robert… - Oncotarget, 2019 - ncbi.nlm.nih.gov
NV669 is an aminosterol derived from squalamine found to possess strong anticancer
effects. The aim of this study was to investigate NV669's beneficial effects on human …